Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Cervical Cancer

Free Subscription 19.10.2026 1 ACS Appl Mater Interfaces 1 Am J Surg Pathol 1 Ann Epidemiol 1 Ann Intern Med 1 Ann Med 1 Ann Surg Oncol 1 Apoptosis 1 Appl Biochem Biotechnol 1 Aust N Z J Obstet Gynaecol 1 BMC Infect Dis 1 BMC Womens Health 1 Cancer Epidemiol 1 Cancer Manag Res 1 Cancer Med 1 Cancer Rep (Hoboken) 2 Cancers (Basel) 1 Cell Signal 1 Cells 1 Clin Transl Radiat Oncol 1 Eur Radiol 1 Expert Opin Pharmacother 1 Front Artif Intell 1 Front Cell Infect Microbiol 5 Front Oncol 1 Front Public Health 1 Gynecol Oncol 3 Gynecol Pelvic Med 1 Health Care Anal 1 Health Expect 1 Hum Vaccin Immunother 1 Immunobiology 1 Int J Cancer 1 Int J Gynaecol Obstet 2 Int J Mol Sci 2 Int J Radiat Oncol Biol Phys 1 J Acquir Immune Defic Syndr 1 J Clin Med 3 J Contemp Brachytherapy 1 J Med Screen 1 J Med Virol 2 J Mol Histol 2 J Vis Exp 1 JAMA Netw Open 2 Lancet 2 Lancet Glob Health 1 Med Decis Making 1 Nucl Med Commun 1 PeerJ 2 PLoS One 1 Purinergic Signal 1 Reprod Sci 1 Rev Med Liege 1 Sci China Life Sci 1 Support Care Cancer 1 Tech Innov Patient Support Radiat Oncol 2 Transl Cancer Res 2 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

ACS Appl Mater Interfaces

1. LEI H, Cui Y, Chen J, Yu Y, et al
   Folic Acid-Functionalized Liposomes Co-Loaded with Doxorubicin and Indocyanine Green for Combined Chemophotothermal Therapy of Cervical Cancer.
   ACS Appl Mater Interfaces. 2026 Oct 13. doi: 10.1021/acsami.6c11448.
   PubMed         Abstract available
   
   

   
   Am J Surg Pathol

2. SHAKIBA D, Dobi A, Eugene HC, Nonogaki H, et al
   Nondiffuse p16 Expression in HPV-Associated and HPV-Independent Cervical Squamous Cell Carcinomas: A Single-Institution Case Series With Emphasis on Histopathologic Features and Molecular Alterations.
   Am J Surg Pathol. 2026;50:1294-1306.
   PubMed         Abstract available
   
   

   
   Ann Epidemiol

3. URBANO A, Sanchez-Soler M, Vazquez-Conejero R, Castejon N, et al
   Age-specific HPV prevalence and genotype distribution in a highly vaccinated population.
   Ann Epidemiol. 2026;123:110276.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

4. SMITH CC, Chelmow D, Freund KM, Burns RB, et al
   How Would You Screen This 26-Year-Old Woman for Cervical Cancer? Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
   Ann Intern Med. 2026 Oct 13. doi: 10.7326/ANNALS-26-02904.
   PubMed         Abstract available
   
   

   
   Ann Med

5. BOSTANCI EI, Korhan S, Yigit S, Caliskan E, et al
   Beyond HPV16/18: genotype distribution of high-risk HPV and cycle threshold values in cervical carcinogenesis spectrum.
   Ann Med. 2026;58:2746866.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

6. BONLOKKE S, Sponholtz S, Jensen PT, Steiniche T, et al
   ASO Author Reflections: From Histopathology to Molecular Assessment: A New Perspective on Sentinel Lymph Nodes in Cervical Cancer.
   Ann Surg Oncol. 2026 Oct 12. doi: 10.1245/s10434-026-20697.
   PubMed        
   
   

   
   Apoptosis

7. FOBIAN SF, Eldering E, Tromp J, Oei AL, et al
   Necroptosis as a key player in cervical cancer progression and management: a systematic review and transcriptomic cross-study consensus analysis.
   Apoptosis. 2026;31:244.
   PubMed         Abstract available
   
   

   
   Appl Biochem Biotechnol

8. CHEN B, Xu C
   Integrated Multi-Omics Analysis of Gut Microbiota-Associated Metabolites and Related Host Molecular Signatures in Cervical Squamous Cell Carcinoma.
   Appl Biochem Biotechnol. 2026;198:9538-9564.
   PubMed         Abstract available
   
   

   
   Aust N Z J Obstet Gynaecol

9. HAMILTON M, Sanday K, Donoghue V, Youlden D, et al
   Timeliness of Primary Radiotherapy for Cervical Cancer in Queensland: A 10 Year Rural-Urban Retrospective Cohort Study.
   Aust N Z J Obstet Gynaecol. 2026;66:e70185.
   PubMed         Abstract available
   
   

   
   BMC Infect Dis

10. CHEE CSM, Tan SSN, Bujang MA, Maharuddin IBW, et al
    Prevalence and genotype distribution of high-risk HPV in Sarawak, East Malaysia.
    BMC Infect Dis. 2026;26:1799.
    PubMed         Abstract available
    
    

    
    BMC Womens Health

11. YUAN S, Wu D, Hu K, Li Y, et al
    Association of vaginal dysbiosis with cervical lesions among women with non-16/18 high-risk HPV infections: a cross-sectional study of 2,264 women in Eastern China.
    BMC Womens Health. 2026;26:522.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol

12. PAGAN-SANTANA Y, Suarez-Ramos T, Umpierre-Catinchi S, Mendez-Lazaro P, et al
    Comparing the five-year relative survival trends of cervical cancer in Puerto Rico and the United States (2000-2021): A joinpoint analysis.
    Cancer Epidemiol. 2026;105:103251.
    PubMed         Abstract available
    
    

    
    Cancer Manag Res

13. TAO H, Pei X, Li H, Xie H, et al
    A Holistic Framework for Cervical Cancer Screening and Risk Stratification: Integrating Etiology, Morphology, Epigenetics, and Microecology.
    Cancer Manag Res. 2026;18:633709.
    PubMed         Abstract available
    
    

    
    Cancer Med

14. WANG S, Liu J, Zhong H, Lei K, et al
    Combined Active Bone Marrow-Sparing Radiotherapy and Prophylactic PEG-rhG-CSF to Reduce Severe Neutropenia During Platinum-Doublet Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer: A Phase II Trial.
    Cancer Med. 2026;15:e72366.
    PubMed         Abstract available
    
    

    
    Cancer Rep (Hoboken)

15. TILAHUN SW, Nega A, Wagaw L, Hillen MA, et al
    Validation of the Amharic Version of the Full and Short Form of the Trust in Oncologist Scale Among Cervical Cancer Patient.
    Cancer Rep (Hoboken). 2026;9:e70718.
    PubMed         Abstract available
    
    

    
    Cancers (Basel)

16. GU Z, Wang C, Zhu Q, Wang W, et al
    Multimodal Large Language Models for Prognostic Prediction in Cervical Cancer Treated with Definitive Chemoradiotherapy: An Exploratory Study of Systematic Multimodal Data Integration.
    Cancers (Basel). 2026;18:3136.
    PubMed         Abstract available
    
    
17. WU Y, Ai Y, Zhang Y, Zhang L, et al
    Multi-Scale MRI, Radiology Reports, and Blood Biomarker-Guided Multimodal Deep Learning for Predicting Postoperative Recurrence in Cervical Cancer: A Multicenter Study.
    Cancers (Basel). 2026;18:3075.
    PubMed         Abstract available
    
    

    
    Cell Signal

18. LIU X, Sheng Y, Wang A, Liang Z, et al
    STAT6 suppresses cervical cancer progression through DDX1-mediated transcriptional activation of GADD45A.
    Cell Signal. 2026 Oct 14:112950. doi: 10.1016/j.cellsig.2026.112950.
    PubMed         Abstract available
    
    

    
    Cells

19. GUO L, He Y, Hu F, Sun Y, et al
    BAP31 Facilitates TGF-beta Trafficking and Secretion and Promotes Dendritic Cell Dysfunction in Cervical Cancer.
    Cells. 2026;15:1765.
    PubMed         Abstract available
    
    

    
    Clin Transl Radiat Oncol

20. HAZIRBULAN A, Kiziltan HS, Cepni K, Talmac MA, et al
    Effects of rectal retractor use on dosimetric parameters, treatment-related adverse events, and clinical outcomes of cervical cancer brachytherapy: A retrospective tertiary-centre study.
    Clin Transl Radiat Oncol. 2026;62:101302.
    PubMed         Abstract available
    
    

    
    Eur Radiol

21. NINKOVA RV, Bottazzi S, Lakhman Y, Gui B, et al
    ESR Essentials: uterine cancers-practice recommendations by the European Society of Urogenital Radiology.
    Eur Radiol. 2026;36:8409-8421.
    PubMed         Abstract available
    
    

    
    Expert Opin Pharmacother

22. DUENAS-GONZALEZ A, Pastrana-Peralta P, Romo-Perez A, Chavez-Blanco A, et al
    Combination therapies for the treatment of locally advanced and advanced cervical cancer.
    Expert Opin Pharmacother. 2026 Oct 13. doi: 10.1080/14656566.2026.2749633.
    PubMed         Abstract available
    
    

    
    Front Artif Intell

23. KANNADOSS N, Rangasamy K
    A comprehensive study on cervical cancer diagnosis using deep learning and artificial intelligence techniques.
    Front Artif Intell. 2026;9:1943994.
    PubMed         Abstract available
    
    

    
    Front Cell Infect Microbiol

24. ZHAO Y, Wang X, Yin R, Li M, et al
    A multi-centre study on cervical cancer screening reveals population-related impact on cervical intraepithelial neoplasia rate.
    Front Cell Infect Microbiol. 2026;16:1920297.
    PubMed         Abstract available
    
    

    
    Front Oncol

25. MINAMITANI M, Tsuyoshi H, Naito T, Nakamoto Y, et al
    Successful conservative management of hepatic portal venous gas complicating severe immune-related gastrointestinal injury during pembrolizumab-based concurrent chemoradiotherapy for cervical cancer: a mechanistic case report.
    Front Oncol. 2026;16:1942174.
    PubMed         Abstract available
    
    
26. WANG J, Xu X, Li Q
    Advances in gammadelta T cell-mediated immune surveillance in cervical cancer.
    Front Oncol. 2026;16:1919105.
    PubMed         Abstract available
    
    
27. WANG X, Zhang Z, Chen M, Luo L, et al
    Ginsenoside Rb2 promotes p62-mediated LDHA autophagic degradation to inhibit H3K18la-dependent PD-L1 transcription in cervical cancer.
    Front Oncol. 2026;16:1962784.
    PubMed         Abstract available
    
    
28. MA CY, Fu Y, Zhang L, Liu L, et al
    CT-based deep learning auto-segmentation of high-risk clinical target volume in CT-guided cervical cancer brachytherapy: a single-center pragmatic study.
    Front Oncol. 2026;16:1936913.
    PubMed         Abstract available
    
    
29. LI C, Ao H, Chen G, Wang F, et al
    Correction: The interaction of CDH20 With beta-catenin inhibits cervical cancer cell migration and invasion via TGF-beta/Smad/SNAIL mediated EMT.
    Front Oncol. 2026;16:1965794.
    PubMed         Abstract available
    
    

    
    Front Public Health

30. ZHANG K, Chen Q, Cai R
    Association of a multimodal perioperative nutritional/ERAS care pathway with postoperative infectious complications following radical hysterectomy for cervical cancer: a retrospective nonconcurrent cohort study.
    Front Public Health. 2026;14:1950549.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol

31. CHALIF J, Morton M, O'Connor R, Gonzalez A, et al
    A second chance? Outcomes of immunotherapy retreatment after prior checkpoint inhibitor exposure in endometrial and cervical cancer.
    Gynecol Oncol. 2026;214:59-65.
    PubMed         Abstract available
    
    

    
    Gynecol Pelvic Med

32. DELGADO H, Lopes C, Queiroz G, Lima PH, et al
    Gynecologic management of cervical cancer patients undergoing immunotherapy: an up-to-date narrative review.
    Gynecol Pelvic Med. 2026;9:35.
    PubMed         Abstract available
    
    
33. WANG C, Xu C, He X, Wang W, et al
    Survival trends and prognostic factors of metastatic cervical cancer: a population-based cohort study.
    Gynecol Pelvic Med. 2026;9:28.
    PubMed         Abstract available
    
    
34. WANG S, Guo M, Lu L, Wu N, et al
    Factors influencing cervical cancer symptom help-seeking behavior: a qualitative study from a social ecological perspective.
    Gynecol Pelvic Med. 2026;9:26.
    PubMed         Abstract available
    
    

    
    Health Care Anal

35. GOKDUMAN KELES M, Toker E
    Relationships Among Cancer Screening Participation, E-Health Literacy, and Healthy Lifestyle Behaviors in a Group of Turkish Women: A Structural Equation Modeling Analysis.
    Health Care Anal. 2026;34:529-543.
    PubMed         Abstract available
    
    

    
    Health Expect

36. JARRAR R, Robb KA, Murphy MK, Sadiq C, et al
    Acceptability of a Peer-Led Faith-Based Intervention to Improve Breast, Bowel and Cervical Cancer Screening Uptake Among UK Muslim Women: A Qualitative Evaluation.
    Health Expect. 2026;29:e70935.
    PubMed         Abstract available
    
    

    
    Hum Vaccin Immunother

37. WALMSLEY S, Vajdic CM, Bishop GM, Long R, et al
    HPV vaccination coverage and barriers for people with disability: A scoping review.
    Hum Vaccin Immunother. 2026;22:2738264.
    PubMed         Abstract available
    
    

    
    Immunobiology

38. NAVAKANITWORAKUL R, Wanso D, Molika P, Leetanaporn K, et al
    Peripheral FOXP3+ regulatory T cells as potential predictive markers of concurrent chemoradiation therapy response in locally advanced cervical cancer.
    Immunobiology. 2026;231:153255.
    PubMed         Abstract available
    
    

    
    Int J Cancer

39. LEHTINEN M, Llobet MO, Eriksson T, Baussano I, et al
    Controlled Trial of Cervical Cancer Screening Frequency Among Human Papillomavirus Vaccinated Women II: Cervical Pre-Cancer End-Points by Specific Non-Vaccine HPV Types.
    Int J Cancer. 2026 Oct 15. doi: 10.1002/ijc.70753.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

40. KAUR S, Mohanta P, Joshi B, Jain V, et al
    Cervical tuberculosis mimicking carcinoma of the cervix in a patient with long-standing secondary amenorrhea.
    Int J Gynaecol Obstet. 2026;175:1060-1062.
    PubMed         Abstract available
    
    

    
    Int J Mol Sci

41. CHEW YY, Sharma A, Goh SSL, Mat Ali NA, et al
    Vaginal Microbial Risk Factors Associated with Human Papillomavirus-Induced Cervical Intraepithelial Neoplasia: A Systematic Review.
    Int J Mol Sci. 2026;27:8625.
    PubMed         Abstract available
    
    
42. TAIRA Y, Kudaka W, Shimoji Y, Nakamoto T, et al
    Advances in Treatment of Refractory Advanced and Recurrent Cervical Adenocarcinoma: Molecular Heterogeneity and Differences from Squamous Cell Carcinoma.
    Int J Mol Sci. 2026;27:8645.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

43. BARCELLINI A, Contreras JA, Krause KJ, Amos RA, et al
    Particle Beam Radiotherapy for Gynecologic Cancers: A Scoping Review and Expert Opinion by the Particle Therapy Cooperative Group - Gynecologic Subcommittee.
    Int J Radiat Oncol Biol Phys. 2026 Aug 14:S0360-3016(26)04155.
    PubMed         Abstract available
    
    
44. PORTOCARRERO-BONIFAZ A, Giap F, Nieto K
    Less Dose, More Immunity? Reframing Proton Therapy for Cervical Cancer in the Pembrolizumab Era.
    Int J Radiat Oncol Biol Phys. 2026;126:1320-1322.
    PubMed        
    
    

    
    J Acquir Immune Defic Syndr

45. GUILLAUME D, Olson S, Dionne JA, Alcaide ML, et al
    Prevalence and predictors of abnormal cervical cytology among women living with HIV and without HIV from the MACS/WIHS combined cohort study.
    J Acquir Immune Defic Syndr. 2026 Jul 7. doi: 10.1097/QAI.0000000000003928.
    PubMed         Abstract available
    
    

    
    J Clin Med

46. WANG Y, Guan S, Wang M, Lv Y, et al
    Vaginal Cuff Length and Time to Postoperative Stump Recurrence After Hysterectomy for Cervical Cancer: An Exploratory Single-Institution Study.
    J Clin Med. 2026;15:7653.
    PubMed         Abstract available
    
    

    
    J Contemp Brachytherapy

47. CAO Y, Wickramage IS, Li C, Wang Q, et al
    Three-dimensional-printed template-assisted image-guided brachytherapy for cervical cancer: Technology, dosimetry, and clinical implementation.
    J Contemp Brachytherapy. 2026;18:319-333.
    PubMed         Abstract available
    
    
48. KONGKUM S, Dangsamak P, Nakkrasae P, Prasartseree T, et al
    Dosimetric impact of intrarectal gas removal by Foley catheter on image-guided adaptive brachytherapy in cervical cancer patients.
    J Contemp Brachytherapy. 2026;18:248-254.
    PubMed         Abstract available
    
    
49. HUANG W, Cui H, Wei D, Li X, et al
    Dosimetric impact of computed tomography slice thickness-induced applicator reconstruction uncertainties in three-dimensional brachytherapy for cervical cancer.
    J Contemp Brachytherapy. 2026;18:271-278.
    PubMed         Abstract available
    
    

    
    J Med Screen

50. SEPPANEN RM, Lamminmaki M, Partanen VM
    Disparities in participation in the Finnish cervical cancer screening programme: The role of birth country, education level and age.
    J Med Screen. 2026 Oct 10:9691413261495461. doi: 10.1177/09691413261495461.
    PubMed         Abstract available
    
    

    
    J Med Virol

51. MIKLUS M, Poljak M, Mlakar J, Cokan A, et al
    The Role of Methylation Marker FAM19A4/mir124-2 and HPV Genotype in Active Surveillance of Women With Cervical Intraepithelial Neoplasia Grade 2 (CIN2).
    J Med Virol. 2026;98:e71175.
    PubMed         Abstract available
    
    

    
    J Mol Histol

52. COLIN-VAL Z, Reyes-Nava LA, Garcia DA, Beltran-Isabeles D, et al
    Lycopene inhibits proliferation, induces apoptosis, and suppresses migration in cervical cancer cells: involvement of PI3K/Akt signaling.
    J Mol Histol. 2026;57:346.
    PubMed         Abstract available
    
    
53. PAN C, Li M
    FAM43B mediates BMAL1-driven regulation of ERK signaling to promote cervical cancer progression.
    J Mol Histol. 2026;57:345.
    PubMed         Abstract available
    
    

    
    J Vis Exp

54. XIA L, Ye Y
    High-risk Human Papillomavirus Genotypes in Women Undergoing Cervical Screening in Leshan, China: Real-time and Nested Multiplex PCR.
    J Vis Exp. 2026;.
    PubMed         Abstract available
    
    
55. YANG H, Du Y, Feng Y, Zhan Q, et al
    Salvianolic Acid B Suppresses Epithelial-Mesenchymal Transition-Associated Phenotypes in Cervical Cancer Cells via GPIb Alpha/LYN/TWIST1 Signaling.
    J Vis Exp. 2026;.
    PubMed         Abstract available
    
    

    
    JAMA Netw Open

56. XIE Y, Nguyen L, Le YC, Zamorano A, et al
    Cervical Cancer Screening Rates by Race and Ethnicity, Age, Language, and Census Region.
    JAMA Netw Open. 2026;9:e2639938.
    PubMed         Abstract available
    
    

    
    Lancet

57. CLIFFORD GM, Wei F
    WHO should adjust its cervical cancer plan - Authors' reply.
    Lancet. 2026;408:1550.
    PubMed        
    
    
58. SUBA EJ
    WHO should adjust its cervical cancer plan.
    Lancet. 2026;408:1549-1550.
    PubMed        
    
    

    
    Lancet Glob Health

59. THE LANCET GLOBAL HEALTH EDITO
    Expression of concern: Global feasibility of cervical cancer elimination: a multidimensional scenario-based modelling analysis across 175 countries.
    Lancet Glob Health. 2027 Sep 24:104112. doi: 10.1016/j.langlo.2026.104112.
    PubMed        
    
    
60. SERRANO B, Roura E, Alemany L, de Sanjose S, et al
    2022 WHO estimates for overall and human papillomavirus test-based cervical cancer screening coverage worldwide: a review and synthetic analysis.
    Lancet Glob Health. 2027 Jun 23:104044. doi: 10.1016/j.langlo.2026.104044.
    PubMed         Abstract available
    
    

    
    Med Decis Making

61. DE KOK IMCM, de Bondt DD, Naslazi E, Killen J, et al
    Why QALY Estimates Differ in Cervical Cancer Screening: An In-Depth Exploration Using CISNET Comparative Modeling.
    Med Decis Making. 2026 Oct 15:272989X261489534. doi: 10.1177/0272989X261489534.
    PubMed         Abstract available
    
    

    
    Nucl Med Commun

62. ELSEWAFY M, Knox N, Punchihewa C, Amro S, et al
    The impact and value of [18F]-FDG PET-CT on management of patients with cervical cancer with service evaluation audited against national evidence-based PET-CT guidelines.
    Nucl Med Commun. 2026 Oct 13. doi: 10.1097/MNM.0000000000002248.
    PubMed         Abstract available
    
    

    
    PeerJ

63. LI X, Luan X, Sun Y, Huang L, et al
    Prediction of prognosis and treatment effect of cervical cancer by immunogenic cell death-related genes.
    PeerJ. 2026;14:e21635.
    PubMed         Abstract available
    
    

    
    PLoS One

64. SZMIGIEL-SOJA A, Kot J, Sienko-Hans K, Gawron I, et al
    Psychological distress among women with abnormal cervical cancer screening results in Poland: Validation of the Polish version of the Cervical Dysplasia Distress Questionnaire (CDDQ-PL).
    PLoS One. 2026;21:e0360240.
    PubMed         Abstract available
    
    
65. HUANG Y, Huang J, Jiang H, Wei Y, et al
    Evaluation of HPV E6/E7 mRNA in predicting recurrence after Leep in cervical intraepithelial neoplasia: A study of negative findings.
    PLoS One. 2026;21:e0360914.
    PubMed         Abstract available
    
    

    
    Purinergic Signal

66. LI R, Xiong HY, Chen SY, Tang Y, et al
    Targeting P2Y(14)R inhibits proliferation of cervical cancer cells and organoids and activates cAMP/PKA/CREB signaling pathway.
    Purinergic Signal. 2026;22:78.
    PubMed         Abstract available
    
    

    
    Reprod Sci

67. XU C, Xu Y, Qingcao, Luo G, et al
    Effects of Telomere Related Senescence-Genes in Cervical Cancer.
    Reprod Sci. 2026 Oct 9. doi: 10.1007/s43032-026-02217.
    PubMed         Abstract available
    
    

    
    Rev Med Liege

68. GOFFINET L, Lebeau A, Gonne E, Danthine D, et al
    [Metastatic or recurrent cervical cancer : current management and therapeutic perspectives].
    Rev Med Liege. 2026;81:562-568.
    PubMed         Abstract available
    
    

    
    Sci China Life Sci

69. CHEN S, Liu F, Li M, Yu J, et al
    Therapeutic HPV vaccine: advancing the global vision to eliminate cervical cancer.
    Sci China Life Sci. 2026 Oct 10. doi: 10.1007/s11427-025-3464.
    PubMed        
    
    

    
    Support Care Cancer

70. LI C, Luo Z, Tian L, Deng W, et al
    Prevalence and independent influencing factors of moderate-to-severe cancer-related fatigue (CRF) and its association with Buzhong-Yiqi (BZYQ) use among patients with locally advanced cervical squamous cell carcinoma (LACSCC): a retrospective observat
    Support Care Cancer. 2026;34:1084.
    PubMed         Abstract available
    
    

    
    Tech Innov Patient Support Radiat Oncol

71. BARTEN DLJ, Goudschaal K, Hinnen KA, de Jong R, et al
    Cone beam computed tomography guided online adaptive radiotherapy for cervical Cancer: Two-year single-Centre implementation and clinical experience.
    Tech Innov Patient Support Radiat Oncol. 2026;40:100442.
    PubMed         Abstract available
    
    

    
    Transl Cancer Res

72. DENG S, Li J, Wang Z, Lv R, et al
    Incidence, characteristics, and exploratory analysis of factors associated with pelvic osteitis/osteoradionecrosis after radiotherapy for cervical cancer: a single-center retrospective cohort study with an unmatched case-control analysis.
    Transl Cancer Res. 2026;15:712.
    PubMed         Abstract available
    
    
73. YANG J, Chen H, Tao H, Liu X, et al
    Sequential chemoradiotherapy vs. radiotherapy alone or concurrent chemoradiotherapy after radical resection of stage IA2-IIA1 cervical cancer: a retrospective cohort study.
    Transl Cancer Res. 2026;15:716.
    PubMed         Abstract available
    
    

    
    Vaccine

74. BUTLER TL, Anderson K, Morseu-Diop A, Brotherton JML, et al
    Aboriginal and Torres Strait Islander adolescent and parent perspectives on human papillomavirus vaccination through the School Immunisation Program in Queensland, Australia: a qualitative study.
    Vaccine. 2026;93:129170.
    PubMed         Abstract available
    
    
75. DICKERSON JC, Adeyemo P, Kim N, Ighodaro E, et al
    Effect of a comic book-based educational intervention on human papillomavirus vaccine knowledge and safety perception among girls aged 9-14 in Nigeria.
    Vaccine. 2026;93:129194.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum